These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. High local control and low ocular toxicity using ultra-low-dose "boom-boom" radiotherapy for indolent orbital lymphoma. Shelukar S; Fernandez C; Bas Z; Komarnicky L; Lally SE; Shields CL; Binder A; Porcu P; Alpdogan O; Martinez-Outschoorn U; Shi W Chin Clin Oncol; 2022 Dec; 11(6):44. PubMed ID: 36632978 [TBL] [Abstract][Full Text] [Related]
5. Low grade, indolent lymphomas of the head and neck: Comparative toxicity of standard versus very low dose radiation therapy. Chelius M; Chau K; Yang J; Hajj C; Imber B; Yahalom J Hematol Oncol; 2021 Aug; 39(3):304-312. PubMed ID: 33733514 [TBL] [Abstract][Full Text] [Related]
6. Localized low-dose radiotherapy for follicular lymphoma: history, clinical results, mechanisms of action, and future outlooks. Ganem G; Cartron G; Girinsky T; Haas RL; Cosset JM; Solal-Celigny P Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):975-82. PubMed ID: 20970029 [TBL] [Abstract][Full Text] [Related]
7. Repeated courses of low-dose 2 × 2 Gy radiation therapy in patients with indolent B-cell non-Hodgkin lymphomas. Saleh K; Michot JM; Schernberg A; Lazarovici J; Chahine C; Danu A; Khalife-Saleh N; Rossignol J; Ghez D; Martin V; Mazeron R; Fermé C; Boros A; Ribrag V; Girinsky T Cancer Med; 2020 Jun; 9(11):3725-3732. PubMed ID: 32249547 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of low-dose radiotherapy (2 Gy × 2) in the treatment of marginal zone and mucosa-associated lymphoid tissue lymphomas. Cerrato M; Orlandi E; Vella A; Bartoncini S; Iorio GC; Bongiovanni D; Capriotti F; Boccomini C; Vassallo F; Cavallin C; De Luca V; Giglioli FR; Ricardi U; Levis M Br J Radiol; 2021 Jul; 94(1123):20210012. PubMed ID: 34111959 [TBL] [Abstract][Full Text] [Related]
9. Effective Pain Control With Very Low Dose Palliative Radiation Therapy for Patients With Multiple Myeloma With Uncomplicated Osseous Lesions. Price JG; Niedzwiecki D; Oyekunle T; Arcasoy MO; Champ CE; Kelsey CR; Salama JK; Moravan MJ Adv Radiat Oncol; 2021; 6(4):100729. PubMed ID: 34258474 [TBL] [Abstract][Full Text] [Related]